Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
CC transcript
Director departure
Inv. presentation
|
|
Orexigen Therapeutics, Inc. (OREXQ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Telemetry Investments, L.L.C. reports a 6.4% stake in Orexigen Therapeutics, Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| O'Connor Global Multi-Strategy Alpha Master Ltd reports a 10% stake in Orexigen Therapeutics, Inc. |
| 02/11/2019 |
SC 13G/A
| Man Group plc reports a 0% stake in OREXIGEN THERAPEUTICS, INC. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 0% stake in Orexigen Therapeutics, Inc. |
| 02/09/2018 |
SC 13G/A
| Man Group plc reports a 8.1% stake in Orexigen Therapeutics, Inc. |
| 08/10/2017 |
SC 13G/A
| Telemetry Investments, L.L.C. reports a 7.6% stake in Orexigen Therapeutics, Inc. |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2016 |
SC 13G/A
| Foresite Capital Fund II, L.P. reports a 7.7% stake in Orexigen Therapeutics, Inc. |
| 02/09/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/15/2013 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 9.2% stake in OREXIGEN THERAPEUTICS INC. |
| 03/12/2012 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 9.8% stake in Orexigen Therapeutics, Inc. |
| 02/14/2012 |
SC 13G/A
| SAC Capital Advisors LP reports a 0% stake in OREXIGEN THERAPEUTICS, INC. |
| 02/10/2012 |
SC 13G/A
| Scale Venture Partners II, LP reports a 5.7% stake in Orexigen Therapeutics, Inc. |
| 02/15/2011 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 0% stake in Orexigen Therapeutics, Inc. |
| 02/10/2011 |
SC 13G/A
| Scale Venture Partners II, LP has filed a Schedule 13D for Orexigen Therapeutics, Inc. |
| 02/10/2011 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 0% stake in Orexigen Therapeutics, Inc. |
| 07/12/2010 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 10.3% stake in Orexigen Therapeutics, Inc. |
| 06/17/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 04/12/2010 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 7.2% stake in Orexigen Threapeutics Inc |
| 02/10/2010 |
SC 13G/A
| Orexigen Therapeutics, Inc. reports a 4.3% stake in Orexigen Therapeutics, Inc. |
| 02/10/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/28/2010 |
SC 13G/A
| Scale Venture Partners II, LP has filed a Schedule 13D for Orexigen Therapeutics, Inc. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2009 |
SC 13G/A
| SOFINNOVA VENTURE PARTNERS VI L P reports a 8.1% stake in Orexigen Therapeutics, Inc. |
| 02/10/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/06/2009 |
SC 13G/A
| DOMAIN PARTNERS V LP reports a 10.3% stake in Orexigen Therapeutics, Inc. |
|
|